Roche has a 127 history and has grown into one of the world’s largest biotech companies, as well
as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative
solutions across major disease areas.
Roche has been at the forefront of cancer research and treatment for over 50 years, with
medicines for breast, skin, colon, ovarian, lung and numerous other cancers. Roche’s ultimate
vision is to prevent and provide cures for cancer in all its forms. The organisation is focused on
pushing for progress in cancer prevention, increasing disease awareness, developing innovative
screening and diagnostic technologies and advancing the understanding of the disease and its
causes.
Roche researchers have the freedom to explore the cutting edge of science and technology, and
can deepen their understanding of the biology and immunology of cancer to make this vision a
reality sooner .
